Effects of the dihydropyridine calcium channel blocker amlodipine on ventricular and atrial protein synthesis in an aortic constriction model of hypertension and, following chronic treatment, in the left ventricle of SHR rats

International Journal of Cardiology

Volumn 58, Issue 3, 1997, Pages 241-255

  Patel, Vinood B ^a   Siddiq, Tahir ^a,b   Sherwood, Roy ^a   Richardson, Peter J ^a   Preedy, Victor R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Bullock County Hospital   (United States)

Author keywords

amlodipine; atria; hypertension; protein synthesis; rat; ventricles

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DNA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SPONTANEOUSLY HYPERTENSIVE RAT;

AMLODIPINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CONTRACTILE PROTEINS; DISEASE MODELS, ANIMAL; HEART ATRIA; HEART VENTRICLES; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MUSCLE PROTEINS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR;

EID: 0031054315     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02872-0     Document Type: Article

References (49)

1. Kaplinsky E. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. Cardiovasc Drugs Ther 1994; 8: 549-556.
2. Purcell H, Coats A. Structural changes in hypertension, the potential for their prevention, arrest and reversal: a focus on felodipine. Br J Clin Pract 1994; 48: 311-316.
3. DeQuattro V. Individualisation of therapy for hypertension in the 1990s: the role of calcium antagonists. Clin Exp Hypertens 1994; 16: 853-864.
4. Ram CV, Ames RP, Applegate WB, Burris JF, Davidov ME, Mroczek WJ. Double-blind comparison of amlodipine and hydrochlorothiazide in patients with mild to moderate hypertension. Clin Cardiol 1994; 17: 251-256.
5. De-Bruijn B, Cocco G, Tyler HM. Multicentre placebo-controlled comparison of amlodipine and atenolol in mild and moderate hypertension. J Cardiovasc Pharmacol 1988; 12: S107-S109.
6. Lorimer AR, Anderson JA, Laher MS, Davies J, Lazarus JH, Taylor SH, Sanghera S. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension. J Hum Hypertens 1994; 8: 65-68.
7. Omvik P, Thaulow E, Herland OB, Eide I, Midha R, Turner RR. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study. J Hypertens 1993; 11: 103-113.
8. Agabiti-Rosei E, Muiesan ML, Rizzoni D, Zulli R, Calebich S, Castellano M, Cavaliere G, Nordio G, Pasini F, Zuccato F. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension. J Cardiovasc Pharmacol 1994; 24: S37-43.
9. Myers MG, Leenen FH, Tanner J. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass. Am J Hypertens 1995; 8: 712-718.
10. Davies RF, Habibi H, Klinke WP, Dessain P, Nadeau C, Phaneuf DC, Lepage S, Raman S, Herbert M, Foris K. Effect of amlodipine, atenolol and their combination on myocardial ischaemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischaemic Study (CASIS) Investigations. J Am Coll Cardiol 1995; 25: 619-625.
11. Deanfield JE, Detry JM, Lichtlen PR, Magnani B, Sellier P, Thaulow E. Amlodipine reduces transient myocardial ischaemia in patients with coronary artery disease: double-blind Circadian Anti-Ischaemic Program in Europe (CAPE Trial). J Am Coll Cardiol 1994; 24: 1460-1467.
12. Taylor SH. The efficacy of amlodipine in myocardial ischaemia. Am Heart J 1989; 118: 1123-1126.
13. Wynne J. In: Isselbacher et al. ed. Update III: Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1982; 399.
14. McKenna W, In: Sobel BE, Julian DG and Hugenholtz PG, eds. Perspectives in Cardiology. London: Current Medical Literature Ltd, 1984; 162-168.
15. Miller JT, O'Rouke RA, Crawford MH. Left atrial enlargement: an early sign of hypertensive heart disease. Am Heart J 1988; 116: 1048-1051.
16. Baker K, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure overload cardiac hypertrophy in rats. Am J Physiol 1990; 259: H324-H332.
17. Kromer EP, Riegger GAJ. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am J Cardiol 1988; 62: 161-163.
18. 3H]phenylalanine. Biochem J 1980; 192: 719-723.
19. Preedy VR, Peters TJ. Synthesis of subcellular protein fractions in the rat heart in vivo in response to chronic ethanol feeding. Cardiovasc Res 1989; 23: 730-736.
20. Siddiq T, Richardson PJ, Hashim IA, Preedy VR. Effect of acute anesthesia on synthesis of contractile and non-contractile proteins on heart muscle and mixed proteins of type I and II fibre rich skeletal muscles of rat. Cardiovasc Res 1991; 25: 110-113.
21. Siddiq T, Richardson PJ, Sherwood RA, Preedy VR. Protein synthesis in pulmonary, cardiac and skeletal muscle in acute hypertension induced by aortic constriction in the rat. Cardiovasc Res 1992; 26: 72-81.
22. Preedy VR, Sugden PH. The effects of fasting or hypoxia on rates of protein synthesis in vivo in subcellular fractions of rat heart and gastrocnemius muscle. Biochem J 1989; 257: 519-527.
23. Gornall AG, Baradawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949; 177: 751-766.
24. Ashford AJ, Pain VM. Effect of diabetes on the rates of synthesis and degradation of ribosomes in rat muscle and liver in vivo. J Biol Chem 1986; 261: 4059-4065.
25. Preedy VR, Paska L, Sugden PH, Schofield PS, Sugden MC. The effects of surgical stress and short term fasting on protein synthesis in vivo in diverse tissues of the mature rat. Biochem J 1988; 250: 179-188.
26. Naimark B, Axelsson J, Sigurdsson SB, Stephens NL. Echocardiographic indices and their relationship to the blood pressure response to ergometric exercise in apparently healthy men. Can J Cardiol 1991; 7: 131-137.
27. Cuspidi C, Sampieri L, Angioni L, Boselli L, Bragato R, Leonetti G, Zanchetti A. Right ventricular wall thickness and function in hypertensive patients with and without left ventricular hypertrophy: echo-Doppler study. J Hypertens 1989; 7: S108-S109.
28. Olubodun JO, Cole TO, Falase AO, Olatunde S, Lawal A. Electrocardiographic hypertrophic patterns in hypertensive Nigerians. Int J Cardiol 1991; 30: 97-102.
29. Magid NM, Borer JS, Young MS, Wallerson DC, DeMonteiro C. Suppression of protein degradation in progressive cardiac hypertrophy of chronic aortic regurgitation. Circulation 1993; 87: 1249-1257.
30. Magid NM, Wallerson DC, Borer JS. Myofibrillar protein turnover in cardiac hypertrophy due to aortic regurgitation. Cardiology 1993; 82: 20-29.
31. Fleckenstein A. Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Harris P and Opie L, eds. Calcium and the Heart. Proceedings of the Meeting of the European Section of the International Study Group for Research in Cardiac Metabolism. London: Academic Press, 1970; 135-188.
32. Burges RA, Dodd MG, Gardiner DG. Pharmacologic profile of amlodipine. Am J Cardiol 1989; 64: 101-201.
33. Schwartz S. Calcium antagonists: review and perspective on mechanism of action. Am J Cardiol 1989; 64: 31-91.
34. Abernethy DR. The pharmacokinetic profile of amlodipine. Am Heart J 1989; 118: 1100-1103.
35. Schwartz S, Zwietan Van, Matlib MA, Millard RW. A symposium: pharmacology and therapeutic considerations of amlodipine. Am J Cardiol 1989; 64: 11-21.
36. Ruvolo G, Greco E, Speziale G, Di-Natale M, Marino B. The effect on left ventricular mass of treatment with amlodipine and diet therapy in obese patients with arterial hypertension. Minnerva i-Cardioangiol 1994; 24: 289-292.
37. Coleman PS, Parmacek MS, Lesch M, Samarel AM. Protein synthesis and degradation during regression of thyroxine-induced cardiac hypertrophy. J Mol Cell Cardiol 1989; 21: 911-925.
38. Samarel AM. Hemodynamic overload and the regulation of myofibrillar protein degradation. Circulation 1993; 87: 1418-1420.
39. Benetos A, Poitevin P, Prost PL, Safar ME, Levy BI. Life survival and cardiovascular structures following selective beta-blockade in spontaneously hypertensive rats. Am J Hypertens 1994; 7: 186-192.
40. Ito H, Hiroe M, Hirata Y, Fujisaki H, Adachi S, Akimoto H, Ohta Y, Marumom F. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 1994; 89: 2198-2203.
41. French WJ, Garner D, Adomian GE, Averill W, Laks MM. Verapamil induced ventricular hypertrophy in conscious dogs. Cardiovas Res 1989; 23: 695-701.
42. Keung E, Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circ Res 1989; 64: 753-763.
43. Morgan HE, Baker KM. Cardiac hypertrophy, mechanical, neural and endocrine dependence. Circulation 1989; 83: 13-25.
44. Patel VB, Siddiq T, Richardson PJ, Preedy VR. Protein synthesis in the hypertrophied heart of spontaneously hypertensive rats and a comparison of the effects of an ACE-inhibitor and a calcium channel antagonist. Cell Biochem Func 1995; 13: 111-124.
45. Liebson PR, Granditis GA, Dianzumba S, Prineas RJ, Grimm Jr RH, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91: 698-706.
46. Cheng CP, Noda T, Nordlander M, Ohno M, Little WC. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance. J Pharmacol Exp Ther 1994; 268: 1232-1241.
47. Ferrari P, Giachino D, Weidmann P, Shaw S, Riesen W, Neuner N, Keller U, Heynen G. Unaltered insulin sensitivity during calcium channel blockade with amlodipine. Eur J Clin Pharmacol 1991; 41: 109-113.
48. Osterloh I. The safety of amlodipine. Am Heart J 1989; 118: 1114-1120.
49. Letizia C, De-Ciocchis A, Cerci S, Coassin S, Fisher H, Tarsitani P, Scavo D. Amlodipine in ambulatory hypertensive patients: humoural and haemodynamic effects. Int J Clin Pharmacol Res 1993; 13: 151-159.